Inorganic Nanoparticles in Cancer Therapy

By S. Bhattacharyya, Rachel A. Kudgus, Resham Bhattacharya, P. Mukherjee. Pharmaceutical Research, 2010

367 citations recorded by the source corpus.

ABSTRACTNanotechnology is an evolving field with enormous potential for biomedical applications. The growing interest to use inorganic nanoparticles in medicine is due to the unique size- and shape-dependent optoelectronic properties. Herein, we will focus on gold, silver and platinum nanoparticles, discussing recent developments for therapeutic applications with regard to cancer in terms of nanoparticles being used as a delivery vehicle as well as therapeutic agents. We will also discuss some of the key challenges to be addressed in future studies.

Subfields: Biomaterials, Biomedical Engineering, Electronic, Optical and Magnetic Materials

View Paper: https://www.semanticscholar.org/paper/f62ce373a2984a4f393723bccd931f254e476391

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. E. Holler
2. J. Ljubimova
3. J. Markman
4. A. Rekechenetskiy

Citations in the corpus

• Nanomedicine therapeutic approaches to overcome cancer drug resistance (2013, background): “presently understood due to the acute in vivo toxicity [15].”
• Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems (2022, background): “On the other side, in active targeting strategy, MNPs are conjugated with various active ligands that bind with specific cell surface receptors and ultimately lead to take the load to the desired site and release the drug [69].”